Drugs / Pan-Salmonella-without-Alum
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07663032 | Jun 2026 → Nov 2027 expected | salmonellosis | GlaxoSmithKline | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pan-Salmonella-without-Alum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07663032 ↗ |
| Modality | Vaccine | “candidate Pan-Salmonella-without-Alum vaccine” NCT07663032 ↗ |